Cargando…

Circulating tumor cells in the early detection of human cancers

Cancer is a severe disease with high morbidity and mortality globally. Thus, early detection is emerging as an important topic in modern oncology. Although the strategies for early detection have developed rapidly in recent decades, they remain challenging due to the subtle symptoms in the initial s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Zixin, Wu, Junyu, Lu, Yuanjun, Chan, Yau-Tuen, Zhang, Cheng, Wang, Di, Luo, Dan, Huang, Yuan, Feng, Yibin, Wang, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134923/ https://www.ncbi.nlm.nih.gov/pubmed/35637960 http://dx.doi.org/10.7150/ijbs.71768

Ejemplares similares

Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis
por: Chan, Yau-tuen, et al.
Publicado: (2023)

Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma
por: Wu, Junyu, et al.
Publicado: (2023)

The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development
por: Yuan, Hongchao, et al.
Publicado: (2021)

Thioredoxin-interacting protein-activated intracellular potassium deprivation mediates the anti-tumour effect of a novel histone acetylation inhibitor HL23, a fangchinoline derivative, in human hepatocellular carcinoma
por: Lu, Yuanjun, et al.
Publicado: (2022)

CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
por: Chan, Yau-Tuen, et al.
Publicado: (2022)

Potential Focal Adhesion Kinase Inhibitors in Management of Cancer: Therapeutic Opportunities from Herbal Medicine
por: Chen, Feiyu, et al.
Publicado: (2022)

Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
por: Lu, Yuanjun, et al.
Publicado: (2020)

The toxicology and detoxification of Aconitum: traditional and modern views
por: Chan, Yau-Tuen, et al.
Publicado: (2021)

Characterization of cuproptosis in gastric cancer and relationship with clinical and drug reactions
por: Chen, Guoming, et al.
Publicado: (2023)

PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma
por: Wang, Ning, et al.
Publicado: (2021)

Ancient Chinese Medicine Herbal Formula Huanglian Jiedu Decoction as a Neoadjuvant Treatment of Chemotherapy by Improving Diarrhea and Tumor Response
por: Chan, Yau-Tuen, et al.
Publicado: (2020)

Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?
por: Chan, Yau-Tuen, et al.
Publicado: (2020)

Systematic Review with Meta-Analysis: Effectiveness and Safety of Acupuncture as Adjuvant Therapy for Side Effects Management in Drug Therapy-Receiving Breast Cancer Patients
por: Chan, Yau-Tuen, et al.
Publicado: (2021)

Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
por: Lu, Yuanjun, et al.
Publicado: (2022)

Lysyl Oxidase‐Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis
por: Tan, Hor‐Yue, et al.
Publicado: (2021)

Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde
por: Wang, Ning, et al.
Publicado: (2017)

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
por: Chen, Guoming, et al.
Publicado: (2022)

The Role and Mechanisms of Selenium Supplementation on Fatty Liver-Associated Disorder
por: Xu, Lin, et al.
Publicado: (2022)

The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
por: Jiang, Xue, et al.
Publicado: (2019)

The functional role of long noncoding RNA in resistance to anticancer treatment
por: Qu, Yidi, et al.
Publicado: (2020)

The Significance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma: Real-Time Monitoring and Moving Targets for Cancer Therapy
por: Chen, Feiyu, et al.
Publicado: (2020)

Circulating tumor cell detection in hepatocellular carcinoma based on karyoplasmic ratios using imaging flow cytometry
por: Liu, Zixin, et al.
Publicado: (2016)

Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
por: Yang, Ying-Chi, et al.
Publicado: (2018)

Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer()
por: Zheng, Xiumei, et al.
Publicado: (2017)

Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer
por: Zhang, Hongyi, et al.
Publicado: (2021)

Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation
por: Wang, Zhoufeng, et al.
Publicado: (2023)

Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing
por: Chen, Ke-Zhong, et al.
Publicado: (2016)

Combined detection of aneuploid circulating tumor‐derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non‐small‐cell lung cancer
por: Lei, Yuanyuan, et al.
Publicado: (2020)

The viable circulating tumor cells with cancer stem cells feature, where is the way out?
por: Luo, Y. T., et al.
Publicado: (2018)

Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment
por: Qu, Yidi, et al.
Publicado: (2019)

The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis
por: Guo, Sumin, et al.
Publicado: (2023)

Circulating cell-free DNA for cancer early detection
por: Gao, Qiang, et al.
Publicado: (2022)

Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer
por: Su, Jian, et al.
Publicado: (2018)

Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer
por: Ning, Dawei, et al.
Publicado: (2021)

Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments
por: Qiu, Jie, et al.
Publicado: (2023)

Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
por: Fiala, Clare, et al.
Publicado: (2018)

Possible role of circulating tumor cells in early detection of lung cancer
por: Poggiana, Cristina, et al.
Publicado: (2020)

Nanotechnology for the detection and kill of circulating tumor cells
por: Gao, Yang, et al.
Publicado: (2014)

Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy
por: Lu, Guang, et al.
Publicado: (2021)

Clinical value and feasibility of ISET in detecting circulating tumor cells in early breast cancer
por: Zeng, Hanling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eo5ofl14tek7v9sfann41slbuh